Determination of the wound-healing activity of a gel cream containing a synthetic selenoxanthene derivative


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Actuality: In this timethere are many different topical medicines inducing wound healing. Many drug forms or their active substances are produced abroad. Active substance selenopyrane with antioxidant, immunomodulatory and other actions was synthesized by research center “Park of activemolecules” (Obninsk). Topical action of substance has not been researched. Research purpose: study of wound healing activity of gel-cream, containing 1% selenopyraneon a model of a full-thickness planar wound in rats. Material and methods: wound healing activity of gel-cream, containing 1% selenopyrane has researched on model of a fullthickness planar wound in rats. Animals were divided into 3 groups: I - intact group; II - group of rats, were treated by gel-cream with selenopyrane; III - group of rats, were treated by dexpanthenol cream (comparison drug). Histological preparations of skin from wound area were made after the end of research (day 14). Results: On the 3rd day of experiment relative wound area in animal treated by selenopyrane was 2.1 % less than in intact rats but differences were not statistically significant. On the 5th day of experiment there was statistically significant difference of relative wound area in II group of animals in comparison with I (intact) group: 45.8% and 64.6% accordingly. Thus, gel-cream containing 1% selenopyran accelerated the onset of the wound process second phase- proliferation phase. Histological research showed that gel-cream containing of 1% selenopyran stimulates the epithelization of the wound defect of the skin with epidermis layers differentiation.

全文:

受限制的访问

作者简介

Daniil Zayats

ZAO «PHARMA-SEVER»

Email: zayatsdanil@yandex.ru
Deputy General Director of Closed joint-stock 4, Georgiy Sedov St., Severodvinsk 164501, Russian Federation

Olga Buyuklinskaya

North State Medical University; Saint Petersburg Chemopharmaceutical University

Email: obfarm@mail.ru
rofessor of the Department of Pharmacology and Pharmacy; Professor of the Department of Pharmacology and Clinical Pharmacology, Doctor of Pharmaceutical Sciences. 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation; 14A, Prof. Popov St., Saint Petersburg 197022, Russian Federation

Kenes Erimbetov

Park of Active Molecules Research Center

Email: erimbetovkt@mail.ru
Head of the Department of Pharmacological Researches, Doctor of Biological Sciences. 3, Kievskoe Shosse, Obninsk, Kaluga Region 249030, Russian Federation

Olga Khoreva

North State Medical University

Email: khoreva69@mail.ru
Associate Professor of the Department of Pathological Anatomy, Forensic Medicine and Law department, PhD. 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

Nicolay Felenko

North State Medical University

Email: nikolaifelenko@yandex.ru
Student of the General Medicine Faculty 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

参考

  1. Галочкин В.А., Галочкина В.П. Органические и минеральные формы селена, их метаболизм, биологическая доступность и роль в организме. Сельскохозяйственная биология. 2011; 4: 3-15.
  2. Lothar A. Heinrich, Betina Pajaziti, Rakhimdzhan Roziev. Drugdelivery system of a Radio-protective inclusion complex. Advanced Materials Research. 2014; 872: 231-6. doi: 10.4028/ href='www.scientific.net/AMR.872.231' target='_blank'>www.scientific.net/AMR.872.231
  3. Изместьева О.С. и др. Экспериментальная оценка адъювантных свойств 9-фенил-симм-октагидроселнокстантена при радиотерапии. Радиационная биология. Радиоэкология. 2017; 57 (4): 391-8. DOI: 10.7868/ S0869803117040051
  4. Никулина А.В., Середа Н.В. Научное обоснование назначения молодняку продуктивных животных биоактивных добавок в условиях селенодефицитного региона. Вестник Оренбургского государственного университета. 2016; 10: 69-73.
  5. Заяц Д.В., Евтушенко Я.А. Обоснование состава композиции лекарственной формы для наружного применения, содержащей синтетическое производное селеноксантена. «Естественные науки и медицина: теория и практика». Сборник статей по материалам II-IV Международной научно-практической конференции. Новосибирск: СибАК, 2018; 2-4 (2): 34-8.
  6. Миронов А.И и др. Руководство по проведению доклинических исследований лекарственных средств, часть 1. М.: Гриф и К, 2012; 944.
  7. Грабарская Е.А., Данилевская Н.В., Дельцов А.А. Изучение ранозаживляющей активности новой многокомпонентной мази. Современные фармако- и биопрепараты. 2015; 3: 48-50.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2021
##common.cookie##